Trial intelligence / Profile preview

PDT and Antibiotics for Generalized Aggressive Periodontitis

NCT03132714Phase 3Completed

Sponsor
Universidade Estadual Paulista
Start
Mar 2015
Primary completion
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of clarithromycin in Generalized Aggressive Periodontitis (GAP) (6 arms), sponsored by Universidade Estadual Paulista. Primary endpoint: Probing Depth at 6 months. Started Mar 2015; status: completed.

02

Drugs

clarithromycin
03

Conditions

Generalized Aggressive Periodontitis (GAP)

Beyond the preview

Go deeper on NCT03132714.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03132714.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call